These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8848534)

  • 1. Catatonia: short-term response to lorazepam and dopaminergic metabolism.
    Northoff G; Wenke J; Demisch L; Eckert J; Gille B; Pflug B
    Psychopharmacology (Berl); 1995 Nov; 122(2):182-6. PubMed ID: 8848534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homovanillic acid concentrations in catatonia.
    Northoff G; Demisch L; Wenke J; Pflug B
    Biol Psychiatry; 1996 Mar; 39(6):436-43. PubMed ID: 8679789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
    Northoff G; Wenke J; Pflug B
    Psychol Med; 1996 May; 26(3):547-53. PubMed ID: 8733213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia.
    Northoff G; Pfennig A; Krug M; Danos P; Leschinger A; Schwarz A; Bogerts B
    Schizophr Res; 2000 Sep; 44(3):193-211. PubMed ID: 10962222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.
    Ungvari GS; Chiu HF; Chow LY; Lau BS; Tang WK
    Psychopharmacology (Berl); 1999 Mar; 142(4):393-8. PubMed ID: 10229064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response rate of lorazepam in catatonia: a developing country's perspective.
    Tibrewal P; Narayanaswamy J; Zutshi A; Srinivasaraju R; Math SB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1520-2. PubMed ID: 20804808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines and the psychopathology of catatonia.
    Ungvari GS; Leung HC; Lee TS
    Pharmacopsychiatry; 1994 Nov; 27(6):242-5. PubMed ID: 7870746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.
    Bush G; Fink M; Petrides G; Dowling F; Francis A
    Acta Psychiatr Scand; 1996 Feb; 93(2):137-43. PubMed ID: 8686484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms.
    Northoff G; Koch A; Wenke J; Eckert J; Böker H; Pflug B; Bogerts B
    Mov Disord; 1999 May; 14(3):404-16. PubMed ID: 10348462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.
    Carroll BT; Goforth HW; Thomas C; Ahuja N; McDaniel WW; Kraus MF; Spiegel DR; Franco KN; Pozuelo L; Muñoz C
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):406-12. PubMed ID: 18070843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam treatment of psychogenic catatonia: an update.
    Salam SA; Kilzieh N
    J Clin Psychiatry; 1988 Dec; 49 Suppl():16-21. PubMed ID: 3058684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride Augmentation in Acute Catatonia.
    Arora M; Banal R; Praharaj SK; Mahajan V
    Am J Ther; 2017; 24(4):e381-e385. PubMed ID: 26270797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.
    Gaind GS; Rosebush PI; Mazurek MF
    J Clin Psychiatry; 1994 Jan; 55(1):20-3. PubMed ID: 8294387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catatonia: an open prospective series with carbamazepine.
    Kritzinger PR; Jordaan GP
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):251-7. PubMed ID: 11602030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of catatonia with lorazepam].
    González-Seijo JC; Ramos Vicente YM; Lastra Martínez I; Carbonell Masía C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(3):90-4. PubMed ID: 8101421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.
    Lin CC; Huang TL
    Compr Psychiatry; 2013 Nov; 54(8):1210-4. PubMed ID: 23856388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of catatonia with low-dose lorazepam.
    Greenfeld D; Conrad C; Kincare P; Bowers MB
    Am J Psychiatry; 1987 Sep; 144(9):1224-5. PubMed ID: 3631326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catatonia].
    Bruijn DJ; Blom JD
    Ned Tijdschr Geneeskd; 2010; 154():A2284. PubMed ID: 20977815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of response to treatment in catatonia.
    Narayanaswamy JC; Tibrewal P; Zutshi A; Srinivasaraju R; Math SB
    Gen Hosp Psychiatry; 2012; 34(3):312-6. PubMed ID: 22387048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.